LFCR (Lifecore Biomedical) Cyclically Adjusted Price-to-FCF : (As of Jun. 24, 2025)

Lifecore Biomedical Cyclically Adjusted Price-to-FCF Chart

Lifecore Biomedical Annual Data
	Trend	May15	May16	May17	May18	May19	May20	May21	May22	May23	May24
Cyclically Adjusted Price-to-FCF		Get a 7-Day Free Trial					-	-	-	-	-

Lifecore Biomedical Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Cyclically Adjusted Price-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lifecore Biomedical's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Cyclically Adjusted Price-to-FCF falls into.

Lifecore Biomedical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Lifecore Biomedical's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2025 is calculated as:

For example, Lifecore Biomedical's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2025 was:

Current CPI (Feb. 2025) = 134.6241.

Lifecore Biomedical Quarterly Data

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Lifecore Biomedical  (NAS:LFCR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.

Lifecore Biomedical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical Business Description